Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.99B |
| 2 |
Apple
AAPL
|
+$2.23B |
| 3 |
NVIDIA
NVDA
|
+$1.92B |
| 4 |
Amazon
AMZN
|
+$1.75B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altair Engineering Inc
ALTR
|
+$152M |
| 2 |
Merck
MRK
|
+$142M |
| 3 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$141M |
| 4 |
ALTM
Arcadium Lithium plc
ALTM
|
+$132M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.36% |
| 2 | Financials | 14.54% |
| 3 | Healthcare | 11.04% |
| 4 | Consumer Discretionary | 10.44% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DMAA
3576
Drugs Made In America Acquisition Corp
DMAA
$260M
| $456K | ﹤0.01% |
+45,462
| New | +$455K |
|
3577
Falcon's Beyond
FBYD
$494M
| $454K | ﹤0.01% |
52,065
+981
| +2% | +$6.78K |
|
3578
Lucid Diagnostics
LUCD
$184M
| $452K | ﹤0.01% |
303,175
+23,671
| +8% | +$28.4K |
|
3579
John Wiley & Sons Class B
WLYB
$2.73B
| $451K | ﹤0.01% |
10,108
+1,126
| +13% | +$47.4K |
|
3580
Regis Corp
RGS
$70.2M
| $451K | ﹤0.01% |
24,844
+2,074
| +9% | +$45.1K |
|
3581
Verrica Pharmaceuticals
VRCA
$87.3M
| $450K | ﹤0.01% |
101,849
+54,122
| +113% | +$350K |
|
|
GBIO
3582
DELISTED
Generation Bio
GBIO
| $449K | ﹤0.01% |
110,842
-2,866
| -3% | -$20.1K |
|
|
SVM
3583
Silvercorp Metals
SVM
$2.53B
| $449K | ﹤0.01% |
116,421
+11,522
| +11% | +$40.5K |
|
3584
Bluerock Homes Trust
BHM
$34.9M
| $448K | ﹤0.01% |
39,384
+1,528
| +4% | +$18.3K |
|
|
AARD
3585
Aardvark Therapeutics
AARD
$173M
| $448K | ﹤0.01% |
+59,600
| New | +$669K |
|
3586
Castellum
CTM
$58.3M
| $444K | ﹤0.01% |
418,525
+118,882
| +40% | +$126K |
|
3587
Modular Medical
MODD
$11.9M
| $443K | ﹤0.01% |
13,538
+2,834
| +26% | +$94.5K |
|
3588
First Seacoast Bancorp
FSEA
$80.3M
| $441K | ﹤0.01% |
37,828
+1,974
| +6% | +$21K |
|
|
STLN
3589
Starling Oncology, Inc. Common Stock
STLN
$641M
| $440K | ﹤0.01% |
385,747
+38,400
| +11% | +$29.7K |
|
3590
Bridger Aerospace
BAER
$74.1M
| $440K | ﹤0.01% |
388,901
+19,284
| +5% | +$42.4K |
|
3591
Oculis Holding
OCS
$704M
| $439K | ﹤0.01% |
23,052
+6,308
| +38% | +$129K |
|
|
SKE
3592
Skeena Resources
SKE
$4.04B
| $438K | ﹤0.01% |
43,483
+4,134
| +11% | +$41.6K |
|
3593
GSI Technology
GSIT
$258M
| $438K | ﹤0.01% |
215,736
+7,013
| +3% | +$20.5K |
|
3594
RF Industries
RFIL
$139M
| $436K | ﹤0.01% |
92,891
+8,271
| +10% | +$37.8K |
|
|
RNTX
3595
Rein Therapeutics
RNTX
$69.9M
| $436K | ﹤0.01% |
246,096
+4,659
| +2% | +$9.78K |
|
3596
Outset Medical
OM
$90.8M
| $436K | ﹤0.01% |
39,356
+1,772
| +5% | +$21.1K |
|
|
VIGL
3597
DELISTED
Vigil Neuroscience
VIGL
| $435K | ﹤0.01% |
244,534
+16,010
| +7% | +$35.9K |
|
3598
Inuvo
INUV
$17M
| $435K | ﹤0.01% |
122,568
+2,179
| +2% | +$9.97K |
|
3599
VolitionRx Ltd
VNRX
$9.34M
| $434K | ﹤0.01% |
38,098
+906
| +2% | +$10.8K |
|
3600
Vale
VALE
$62.6B
| $434K | ﹤0.01% |
43,522
-2,239
| -5% | -$21.2K |
|
Similar funds
Geode Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Geode Capital Management held 4,591 positions worth $1.27T, down 1.4% from $1.29T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Geode Capital Management deployed $47.9B of net new capital in Q1 2025, opening 122 new positions and adding to 3,780 existing holdings. Its largest new stake was Sandisk: 1,936,245 shares worth $92.2M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Merck, an estimated $142M trimmed.
- Geode Capital Management's largest Q1 2025 buy was Sandisk: 1,936,245 shares worth $92.2M.
- Geode Capital Management added most to Microsoft in Q1 2025, an estimated $2.99B increase.
- Geode Capital Management's biggest Q1 2025 reduction was Merck, cutting an estimated $142M.
- Geode Capital Management fully exited Altair Engineering Inc in Q1 2025, selling an estimated $152M.
- Geode Capital Management's ten largest holdings make up 29% of its $1.27T portfolio in Q1 2025.
- Geode Capital Management opened 122 new positions and closed 115 in Q1 2025.
- Geode Capital Management's portfolio value fell 1.4% quarter-over-quarter to $1.27T.
Based on Geode Capital Management's 13F filing for Q1 2025, filed 13 May 2025.